Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Orchid Pharma Ltd

NSE: ORCHPHARMA · BSE: 524372 · Pharmaceuticals & Biotechnology · 30 announcements

Share price
₹1,024.25
Market cap
₹6,134 Cr
Revenue (annual)
₹811.3 Cr
Net profit (annual)
₹20.55 Cr
P/E (TTM)
707.7×Sector 47.4×
Promoter holding
74.45%+4.61% QoQ
FII holding
0.92%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:46 IST BSE
Legal & Regulatory

Orchid Pharma Legal & Regulatory

Orchid Pharma received a Rs.1.67 Crore GST demand for an erroneously refunded amount. The company believes the order is unjustified and plans to appeal.

Value
₹1.67 Cr
17:34 IST NSE
Legal & Regulatory

Orchid Pharma Legal & Regulatory

The National Company Law Tribunal (NCLT), Chennai Bench, dismissed an application filed by DBS Bank against Orchid Pharma Limited. The claim involved lease rent dues during the Corporate Insolvency Resolution Process (CIRP) period. The tribunal's order, dated April 02, 2026, has no quantifiable financial impact on the company.